C4BPA and PLA2G1B showed the most positive (19.8) and negative (0.009) fold changes in gene expression, respectively, when comparing Group B1 differentially expressed mRNA in the post-chemotherapy tumor bed to Group A (Fig. 3C, Supplementary Table 9). This evidence concerns the gene C4BPA and neoplasm.